| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy
|
FERDER, N.S.
|
|
|
8 |
1 |
p. 95-100
|
article
|
| 2 |
Adenosine diphosphate‐inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel
|
GREMMEL, T.
|
|
|
8 |
1 |
p. 37-42
|
article
|
| 3 |
Announcements
|
|
|
|
8 |
1 |
p. 219
|
article
|
| 4 |
Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization
|
HECHLER, B.
|
|
|
8 |
1 |
p. 173-184
|
article
|
| 5 |
Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia
|
TAHER, A.T.
|
|
|
8 |
1 |
p. 54-59
|
article
|
| 6 |
Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2
|
WU, Y.
|
|
|
8 |
1 |
p. 185-193
|
article
|
| 7 |
Coronary atherosclerosis and cardiovascular mortality in hemophilia
|
FOLEY, C.J.
|
|
|
8 |
1 |
p. 208-211
|
article
|
| 8 |
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|
SCHULMAN, S.
|
|
|
8 |
1 |
p. 202-204
|
article
|
| 9 |
Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive
|
SELLENG, S.
|
|
|
8 |
1 |
p. 30-36
|
article
|
| 10 |
Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study
|
KIM, Y.‐K.
|
|
|
8 |
1 |
p. 101-106
|
article
|
| 11 |
Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study
|
COLLINS, P.
|
|
|
8 |
1 |
p. 83-89
|
article
|
| 12 |
Genetic testing for von Willebrand disease: the case against
|
FAVALORO, E.J.
|
|
|
8 |
1 |
p. 6-12
|
article
|
| 13 |
Genetic testing for von Willebrand disease: the case for
|
PEAKE, I.R.
|
|
|
8 |
1 |
p. 13-16
|
article
|
| 14 |
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
|
SIMANEK, R.
|
|
|
8 |
1 |
p. 114-120
|
article
|
| 15 |
Human plasminogen kringle 1–5 reduces atherosclerosis and neointima formation in mice by suppressing the inflammatory signaling pathway
|
CHANG, P.C.
|
|
|
8 |
1 |
p. 194-201
|
article
|
| 16 |
Mean platelet volume: a quick, easy determinant of thrombotic risk?
|
MACHIN, S.J.
|
|
|
8 |
1 |
p. 146-147
|
article
|
| 17 |
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis
|
CHU, S.G.
|
|
|
8 |
1 |
p. 148-156
|
article
|
| 18 |
Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study
|
BRÆKKAN, S.K.
|
|
|
8 |
1 |
p. 157-162
|
article
|
| 19 |
Novel APC‐cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S
|
TRAN, S.
|
|
|
8 |
1 |
p. 129-136
|
article
|
| 20 |
Patients requiring interruption of long‐term oral anticoagulant therapy: the use of fixed sub‐therapeutic doses of low‐molecular‐weight heparin
|
MALATO, A.
|
|
|
8 |
1 |
p. 107-113
|
article
|
| 21 |
Platelet‐bound P‐selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti‐platelet medication
|
STELLOS, K.
|
|
|
8 |
1 |
p. 205-207
|
article
|
| 22 |
Post‐operative platelet count profile: the most reliable tool for identifying patients with true heparin‐induced thrombocypenia after cardiac surgery
|
GRUEL, Y.
|
|
|
8 |
1 |
p. 27-29
|
article
|
| 23 |
Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
|
LE GAL, G.
|
|
|
8 |
1 |
p. 90-94
|
article
|
| 24 |
Reduction in deep vein thrombosis incidence in intensive care after a clinician education program
|
BODDI, M.
|
|
|
8 |
1 |
p. 121-128
|
article
|
| 25 |
Rewards for commitment and success
|
GREAVES, M.
|
|
|
8 |
1 |
p. 1
|
article
|
| 26 |
The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study
|
PALLA, A.
|
|
|
8 |
1 |
p. 68-74
|
article
|
| 27 |
The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome
|
BROUNS, R.
|
|
|
8 |
1 |
p. 75-80
|
article
|
| 28 |
The discovery of the endothelial cell protein C receptor
|
ESMON, C.T.
|
|
|
8 |
1 |
p. 2-5
|
article
|
| 29 |
The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients
|
GURBEL, P.A.
|
|
|
8 |
1 |
p. 43-53
|
article
|
| 30 |
The mitogen‐activated protein kinase signaling pathways: role in megakaryocyte differentiation
|
SÉVERIN, S.
|
|
|
8 |
1 |
p. 17-26
|
article
|
| 31 |
The plasma von Willebrand factor O‐glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs
|
CANIS, K.
|
|
|
8 |
1 |
p. 137-145
|
article
|
| 32 |
The platelet glycoprotein Ib‐IX‐V complex anchors lipid rafts to the membrane skeleton: implications for activation‐dependent cytoskeletal translocation of signaling molecules
|
MUNDAY, A.D.
|
|
|
8 |
1 |
p. 163-172
|
article
|
| 33 |
The prevalence of symptomatic von Willebrand disease in primary care practice
|
BOWMAN, M.
|
|
|
8 |
1 |
p. 213-216
|
article
|
| 34 |
The use of well‐characterized sera for the assessment of new diagnostic enzyme‐immunoassays for the diagnosis of heparin‐induced thrombocytopenia
|
WARKENTIN, T.E.
|
|
|
8 |
1 |
p. 216-218
|
article
|
| 35 |
Thrombophilia and the risk of post‐thrombotic syndrome: retrospective cohort observation
|
SPIEZIA, L.
|
|
|
8 |
1 |
p. 211-213
|
article
|
| 36 |
To bleed or not to bleed – is that a question?
|
ALEDORT, L.M.
|
|
|
8 |
1 |
p. 81-82
|
article
|
| 37 |
Volumetric or time‐based capnography for excluding pulmonary embolism in outpatients?
|
VERSCHUREN, F.
|
|
|
8 |
1 |
p. 60-67
|
article
|
Journal description